Sleep Quality. Sleep disorder, unspecified
Conditions
Interventions
Intervention 1: The intervention group will receive 4000 units of oral vitamin D daily produced by Dana Pharmaceutical Company, which is quite similar in appearance to the drug used in the placebo gro
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 49 Years
Inclusion criteria
Inclusion criteria: Pregnant people with a gestational age of 8 -10 weeks Vitamin D levels below 30 ng/ml
Exclusion criteria
Exclusion criteria: Women with diabetes Vitamin D levels above 30 ng/ml Women with thyroid and parathyroid disorders according to the self-report Women with a body mass index above 30 kg/2m before pregnancy Women with a history of macrosomic neonate Women with pre-pregnancy polycystic ovary syndrome, according to the self-report Women with a history of diabetes or gestational diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep quality score. Timepoint: Before the intervention and 26th week of pregnancy. Method of measurement: Pittsburgh Sleep Quality Questionnaire.;Pregnancy symptoms score. Timepoint: Before the intervention and 26th week of pregnancy. Method of measurement: Pregnancy Symptoms Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: During intervention. Method of measurement: Side effects checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Mirzaee Azandaryani
Tabriz University of Medical Sciences
Outcome results
None listed